statistiche ricercatore

Continente	#
NA - Nord America	513
AS - Asia	451
EU - Europa	262
SA - Sud America	59
AF - Africa	20
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.306

Nazione	#
US - Stati Uniti d'America	496
SG - Singapore	130
VN - Vietnam	96
CN - Cina	92
IT - Italia	58
BD - Bangladesh	57
BR - Brasile	45
IE - Irlanda	44
DE - Germania	38
SE - Svezia	38
HK - Hong Kong	34
FR - Francia	21
ZA - Sudafrica	18
TR - Turchia	14
NL - Olanda	13
FI - Finlandia	11
GB - Regno Unito	8
BE - Belgio	6
CA - Canada	6
CZ - Repubblica Ceca	5
IN - India	5
AR - Argentina	4
AT - Austria	4
IQ - Iraq	4
JP - Giappone	4
MX - Messico	4
RU - Federazione Russa	4
HN - Honduras	3
VE - Venezuela	3
AZ - Azerbaigian	2
BO - Bolivia	2
EC - Ecuador	2
ES - Italia	2
JM - Giamaica	2
LT - Lituania	2
PH - Filippine	2
PL - Polonia	2
PY - Paraguay	2
BG - Bulgaria	1
CH - Svizzera	1
CI - Costa d'Avorio	1
CO - Colombia	1
EG - Egitto	1
GR - Grecia	1
ID - Indonesia	1
JO - Giordania	1
KG - Kirghizistan	1
KH - Cambogia	1
KR - Corea	1
LA - Repubblica Popolare Democratica del Laos	1
MT - Malta	1
MY - Malesia	1
NI - Nicaragua	1
OM - Oman	1
PA - Panama	1
RS - Serbia	1
SY - Repubblica araba siriana	1
TH - Thailandia	1
UA - Ucraina	1
UZ - Uzbekistan	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.306

Nome	#
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value	204
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC)	194
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer	191
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME	163
Vaccines against coronaviruses: The state of the art	157
Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer	152
Divergent PD-1 expression in tissue and circulating CD8 lymphocytes defines an immune profile predictive of the response to nivolumab in advanced NSCLC	106
Analgosedation in Pediatric Emergency Care: A Comprehensive Scoping Review	83
An Update on Reports of Atypical Presentations of Kawasaki Disease and the Recognition of IVIG Non-Responder Children	81
Totale	1.331

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	3	0	0	0	0	0	0	0	0	0	0	0	3
2021/2022	36	0	2	1	2	2	3	4	2	2	3	3	12
2022/2023	181	15	22	9	17	15	22	3	11	51	1	12	3
2023/2024	71	1	4	2	2	4	16	5	4	6	9	8	10
2024/2025	235	5	9	19	23	21	21	19	17	21	15	22	43
2025/2026	667	62	40	69	52	90	32	36	25	108	44	63	46
Totale													1.331